iBio, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults (NCT07487376) | iBio, Inc. | 2026-05-24 |
Track iBio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.